The Indian Pharmacopoeia Commission (IPC) has added 23 new impurities standards and 7 new Indian Pharmacopoeial Reference standards
Molnupiravir is an investigational oral antiviral medicine, for the treatment of mild-to-moderate COVID-19 in at risk adults
Bioanalytical approach to accelerate development efforts in the identification of compounds that can treat chlorine or sulfur mustard injuries
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
Second interchangeable biosimilar product approved by agency
U.S. FDA to decide whether to authorize a booster dose in the coming days
Equity raise to finance growth and investments in the biological space
An amount of Rs. 70.9 crore has been earmarked for funding capital expenditure for the proposed expansion
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) and a comprehensive data set with an expected readout in mid-2022
ZyCoV-D is the first DNA plasmid vaccine in the world for human use, developed indigenously by the company against the Covid-19 virus
Subscribe To Our Newsletter & Stay Updated
